본문 바로가기
KERD
논문KCI 등재

Modulation of Inflammatory Pathways and Adipogenesis by the Action of Gentisic Acid in RAW 264.7 and 3T3-L1 Cell Lines

3

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Gentisic acid (GA), a benzoic acid derivative present in various food ingredients, has been shown to have diverse pharmaceutical activities such as anti-carcinogenic, antioxidant, and hepatoprotective effects. In this study, we used a co-culture system to investigate the mechanisms of the antiinflammatory and anti-adipogenic effects of GA on macrophages and adipocytes, respectively, as well as its effect on obesity-related chronic inflammation. We found that GA effectively suppressed lipopolysaccharide-stimulated inflammatory responses by controlling the production of nitric oxide and pro-inflammatory cytokines and modulating inflammation-related protein pathways. GA treatment also inhibited lipid accumulation in adipocytes by modulating the expression of major adipogenic transcription factors and their upstream protein pathways. Furthermore, in the macrophage–adipocyte co-culture system, GA decreased the production of obesity-related cytokines. These results indicate that GA possesses effective anti-inflammatory and anti-adipogenic activities and may be used in developing treatments for the management of obesity-related chronic inflammatory diseases.

Abstract

Gentisic acid (GA), a benzoic acid derivative present in various food ingredients, has been shown to have diverse pharmaceutical activities such as anti-carcinogenic, antioxidant, and hepatoprotective effects. In this study, we used a co-culture system to investigate the mechanisms of the antiinflammatory and anti-adipogenic effects of GA on macrophages and adipocytes, respectively, as well as its effect on obesity-related chronic inflammation. We found that GA effectively suppressed lipopolysaccharide-stimulated inflammatory responses by controlling the production of nitric oxide and pro-inflammatory cytokines and modulating inflammation-related protein pathways. GA treatment also inhibited lipid accumulation in adipocytes by modulating the expression of major adipogenic transcription factors and their upstream protein pathways. Furthermore, in the macrophage–adipocyte co-culture system, GA decreased the production of obesity-related cytokines. These results indicate that GA possesses effective anti-inflammatory and anti-adipogenic activities and may be used in developing treatments for the management of obesity-related chronic inflammatory diseases.

참고문헌 (45)

  1. Tremmel M, "Economic burden of obesity : a systematic literature review", Int. J. Environ. Res. Public Health, 14, pp.435~ (2017)
  2. Kopelman PG, "Obesity as a medical problem", Nature, 404, pp.635~643 (2000)
  3. Ghoorah K, "Obesity and cardiovascular outcomes : a review", Eur. Heart J. Acute Cardiovasc. Care, 5, pp.77~85 (2016)
  4. Charlton M, "Obesity, hyperlipidemia, and metabolic syndrome", Liver Transplant, 15, pp.S83~ (2009)
  5. Castro A, "Low-grade inflammation and its relation to obesity and chronic degenerative diseases", Rev. Med. Hosp. Gen. Mex, 80, pp.101~105 (2017)
  6. Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance", J. Clin. Invest, 112, pp.1821~1830 (2003)
  7. Monteiro R, "Chronic inflammation in obesity and the metabolic syndrome", Mediators Inflamm, 2010, pp.289645~ (2010)
  8. Wellen KE, "Obesity-induced inflammatory changes in adipose tissue", J. Clin. Invest, 112, pp.1785~1788 (2003)
  9. Shah A, "Adipose inflammation, insulin resistance, and cardiovascular disease", J. Parenter. Enteral Nutr, 32, pp.638~644 (2008)
  10. Suganami T, "A paracrine loop between adipocytes and macrophages aggravates inflammatory changes : role of free fatty acids and tumor necrosis factor α", Arterioscler. Thromb. Vasc. Biol, 25, pp.2062~2068 (2005)
  11. Nishimura S, "Adipose tissue inflammation in obesity and metabolic syndrome", Discov. Med, 8, pp.55~60 (2009)
  12. Abedi F, "A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin : comprehensive pharmacology, toxicology, and some pharmaceutical aspects", Phytother. Res, 34, pp.729~741 (2020)
  13. Russell WR, "Phenolic acid content of fruits commonly consumed and locally produced in Scotland", Food Chem, 115, pp.100~104 (2009)
  14. Onyeneho SN, "Antioxidant activity of durum wheat bran", J. Agric. Food Chem, 40, pp.1496~1500 (1992)
  15. Lubaina A, "Prospects in Bioscience: Addressing the Issues", pp.243~250 (2012), Springer
  16. Soleas GJ, "Toward the fingerprinting of wines : cultivar-related patterns of polyphenolic constituents in Ontario wines", J. Agric. Food Chem, 45, pp.3871~3880 (1997)
  17. Hsieh H, "Medicinal components in Termitomyces mushrooms", Appl. Microbiol. Biotechnol, 102, pp.4987~4994 (2018)
  18. Palacios I, "Antioxidant properties of phenolic compounds occurring in edible mushrooms", Food Chem, 128, pp.674~678 (2011)
  19. Awtry EH, "Aspirin", Circulation, 101, pp.1206~1218 (2000)
  20. Li H, "Antioxidant and anti-inflammatory activities of methanol extracts of Tremella fuciformis and its major phenolic acids", J. Food Sci, 79, pp.C460~C468 (2014)
  21. Sharma S, "Study on prevention of two-stage skin carcinogenesis by Hibiscus rosa sinensis extract and the role of its chemical constituent, gentisic acid, in the inhibition of tumour promotion response and oxidative stress in mice", Eur. J. Cancer Prev, 13, pp.53~63 (2004)
  22. Peskin AV, "A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt(WST-1)", Clin. Chim. Acta, 293, pp.157~166 (2000)
  23. Giustarini D, "Nitrite and nitrate measurement by Griess reagent in human plasma : evaluation of interferences and standardization", Methods Enzymol, 440, pp.361~380 (2008)
  24. Chait A, "Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease", Front. Cardiovasc. Med, 7, pp.22~ (2020)
  25. Clancy RM, "Nitric oxide : a novel mediator of inflammation", Proc. Soc. Exp. Biol. Med, 210, pp.93~101 (1995)
  26. Murakami A, "Targeting NOX, INOS and COX-2 in inflammatory cells : chemoprevention using food phytochemicals", Int. J. Cancer, 121, pp.2357~2363 (2007)
  27. Kawahara K, "Prostaglandin E2-induced inflammation : relevance of prostaglandin E receptors", Biochim. Biophys. Acta Mol. Cell. Biol. Lipids, 1851, pp.414~421 (2015)
  28. Al-Sadi R, "Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene", PLoS One, 9, pp.e85345~ (2014)
  29. Hirao LA, "Early mucosal sensing of SIV infection by paneth cells induces IL-1β production and initiates gut epithelial disruption", PLoS Pathog, 10, pp.e1004311~ (2014)
  30. Al-Sadi R, "TNF-α modulation of intestinal epithelial tight junction barrier is regulated by ERK1", 2activation of Elk-1, 2013, pp.183, 1871~1884
  31. Liu T, "NF-κB signaling in inflammation", Signal. Transduct. Target. Ther, 2, pp.17023~ (2017)
  32. Karin M, "How NF-κB is activated : the role of the IκB kinase(IKK)complex", Oncogene, 18, pp.6867~6874 (1999)
  33. Christian F, "The regulation of NF-κB subunits by phosphorylation", Cells, 5, pp.12~ (2016)
  34. Kaminska B, "MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits", Biochim. Biophys. Acta, 1754, pp.253~262 (2005)
  35. Kim EK, "Pathological roles of MAPK signaling pathways in human diseases", Biochim. Biophys. Acta, 1802, pp.396~405 (2010)
  36. Coskun M, "MAP kinases in inflammatory bowel disease", Clin. Chim. Acta, 412, pp.513~520 (2011)
  37. Ali AT, "Adipocyte and adipogenesis", Eur. J. Cell Biol, 92, pp.229~236 (2013)
  38. Kowalska K, "Cranberries(Oxycoccus quadripetalus)inhibit lipid metabolism and modulate leptin and adiponectin secretion in 3T3-L1 adipocytes", Food Chem, 185, pp.383~388 (2015)
  39. Eberle D, "SREBP transcription factors : master regulators of lipid homeostasis", Biochimie, 86, pp.839~848 (2004)
  40. Chirala SS, "Structure and function of animal fatty acid synthase", Lipids, 39, pp.1045~1053 (2004)
  41. Yu W, "Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells", Mol. Cell. Biochem, 310, pp.11~18 (2008)
  42. Zhang HH, "Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway", PLoS One, 4, pp.e6189~ (2009)
  43. Christodoulides C, "Adipogenesis and WNT signalling", Trends Endocrinol. Metab, 20, pp.16~24 (2009)
  44. Liu J, "Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes", J. Biol. Chem, 279, pp.45020~45027 (2004)
  45. Hsieh C, "Lunasin attenuates obesity-related inflammation in RAW264. 7 cells and 3T3-L1 adipocytes by inhibiting inflammatory cytokine production", PLoS One, 12, pp.e0171969~ (2017)

관련 논문AI추천

이 간행물의 다른 논문 (14건)